📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12933-023-02032-x

PubMed Identifier: 37919773

Publication URI: http://europepmc.org/abstract/MED/37919773

Type: Journal Article/Review

Volume: 22

Parent Publication: Cardiovascular diabetology

Issue: 1

ISSN: 1475-2840